Astrid E. Greijer

1.7k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Astrid E. Greijer is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Astrid E. Greijer has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Astrid E. Greijer's work include Viral-associated cancers and disorders (12 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Polyomavirus and related diseases (5 papers). Astrid E. Greijer is often cited by papers focused on Viral-associated cancers and disorders (12 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Polyomavirus and related diseases (5 papers). Astrid E. Greijer collaborates with scholars based in Netherlands, Indonesia and United States. Astrid E. Greijer's co-authors include P. J. van Diest, Jaap M. Middeldorp, Elsken van der Wall, Reinhard Bos, Petra van der Groep, Avi Shvarts, Herbert M. Pinedo, Gregg L. Semenza, Sybren Meijer and M M Vleugel and has published in prestigious journals such as PLoS ONE, Cancer and Oncogene.

In The Last Decade

Astrid E. Greijer

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma

2003 413 citations Reinhard Bos, Petra van der Groep et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Astrid E. Greijer Netherlands	17	648	590	557	243	140	25	1.4k
Qi-Sheng Feng China	25	711 1.1×	805 1.4×	539 1.0×	157 0.6×	251 1.8×	41	1.7k
Man-Zhi Li China	22	813 1.3×	1.1k 1.9×	490 0.9×	176 0.7×	205 1.5×	30	1.8k
Arjen Brink Netherlands	23	470 0.7×	446 0.8×	263 0.5×	136 0.6×	119 0.8×	41	1.2k
Carlos Villacorta-Martín United States	20	455 0.7×	650 1.1×	311 0.6×	179 0.7×	295 2.1×	44	1.6k
Magnus Sundström Sweden	24	524 0.8×	580 1.0×	300 0.5×	205 0.8×	309 2.2×	40	1.5k
Pathmanathan Rajadurai Malaysia	20	1.1k 1.6×	523 0.9×	402 0.7×	228 0.9×	202 1.4×	60	1.7k
Rekha V. Kumar India	20	405 0.6×	604 1.0×	198 0.4×	124 0.5×	102 0.7×	71	1.2k
Gerhard Dyckhoff Germany	25	582 0.9×	952 1.6×	519 0.9×	252 1.0×	183 1.3×	66	1.9k
Chiara Menin Italy	19	606 0.9×	475 0.8×	157 0.3×	164 0.7×	166 1.2×	66	1.2k
Patricia Ngai Hong Kong	10	886 1.4×	776 1.3×	470 0.8×	135 0.6×	279 2.0×	11	1.6k

Countries citing papers authored by Astrid E. Greijer

Since Specialization

Citations

This map shows the geographic impact of Astrid E. Greijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid E. Greijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid E. Greijer more than expected).

Fields of papers citing papers by Astrid E. Greijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid E. Greijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid E. Greijer. The network helps show where Astrid E. Greijer may publish in the future.

Co-authorship network of co-authors of Astrid E. Greijer

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid E. Greijer. A scholar is included among the top collaborators of Astrid E. Greijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid E. Greijer. Astrid E. Greijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Novalić, Zlata, Sandra A.W.M. Verkuijlen, Jos Eersels, et al.. (2017). Cytolytic virus activation therapy and treatment monitoring for Epstein‐Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. Journal of Medical Virology. 89(12). 2207–2216. 12 indexed citations

Juwana, Hedy, et al.. (2016). Epstein‐Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. International Journal of Cancer. 140(1). 149–162. 42 indexed citations

Novalić, Zlata, Maarten A. Wildeman, Alwin D. R. Huitema, et al.. (2015). Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology. 141(10). 1845–1857. 42 indexed citations

Wildeman, Maarten A., Zlata Novalić, Renske Fles, et al.. (2015). Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group. European Archives of Oto-Rhino-Laryngology. 273(6). 1557–1567. 16 indexed citations

Adham, Marlinda, Maarten A. Wildeman, Soehartati Gondhowiardjo, et al.. (2014). Current Status of Cancer Care for Young Patients with Nasopharyngeal Carcinoma in Jakarta, Indonesia. PLoS ONE. 9(7). e102353–e102353. 16 indexed citations

Adham, Marlinda, Astrid E. Greijer, Sandra A.W.M. Verkuijlen, et al.. (2013). Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients before and after Treatment. Clinical Cancer Research. 19(8). 2175–2186. 54 indexed citations

Large, Tessa Y. S. Le, et al.. (2013). BamHI‐A rightward frame 1, an Epstein–Barr virus‐encoded oncogene and immune modulator. Reviews in Medical Virology. 23(6). 367–383. 46 indexed citations

Wildeman, Maarten A., Zlata Novalić, Sandra A.W.M. Verkuijlen, et al.. (2012). Cytolytic Virus Activation Therapy for Epstein-Barr Virus–Driven Tumors. Clinical Cancer Research. 18(18). 5061–5070. 73 indexed citations

Large, Tessa Y. S. Le, Nicolas Tarbouriech, Dinja Oosterhoff, et al.. (2012). Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation. Viral Immunology. 25(6). 461–470. 23 indexed citations

10.

Hutajulu, Susanna Hilda, Sagung Rai Indrasari, Sylvia Duin, et al.. (2011). Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Molecular Cancer. 10(1). 48–48. 70 indexed citations

11.

Greijer, Astrid E., Pien M. Delis‐van Diemen, Remond J.A. Fijneman, et al.. (2008). Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 452(5). 535–544. 42 indexed citations

12.

Vleugel, M M, Astrid E. Greijer, Reinhard Bos, Elsken van der Wall, & P. J. van Diest. (2006). c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Human Pathology. 37(6). 668–674. 164 indexed citations

13.

Vleugel, M M, Astrid E. Greijer, Elsken van der Wall, & P. J. van Diest. (2005). Mutation analysis of the HIF-1α oxygen-dependent degradation domain in invasive breast cancer. Cancer Genetics and Cytogenetics. 163(2). 168–172. 15 indexed citations

14.

Bos, Reinhard, P. J. van Diest, Petra van der Groep, et al.. (2004). Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Research. 6(4). R450–9. 67 indexed citations

15.

Bos, Reinhard, P. J. van Diest, Petra van der Groep, et al.. (2003). Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1α (HIF-1α). Oncogene. 22(55). 8948–8951. 52 indexed citations

16.

Bos, Reinhard, Petra van der Groep, Astrid E. Greijer, et al.. (2003). Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer. 97(6). 1573–1581. 413 indexed citations breakdown →

17.

Greijer, Astrid E., et al.. (2002). Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA. Journal of Clinical Virology. 24(1-2). 57–66. 29 indexed citations

18.

Greijer, Astrid E., Erik A.M. Verschuuren, Henriëtte Adriaanse, et al.. (2001). Expression Dynamics of Human Cytomegalovirus Immune Evasion GenesUS3, US6,andUS11in the Blood of Lung Transplant Recipients. The Journal of Infectious Diseases. 184(3). 247–255. 15 indexed citations

19.

Greijer, Astrid E., Erik A.M. Verschuuren, Martin C. Harmsen, et al.. (2001). Direct Quantification of Human Cytomegalovirus Immediate-Early and Late mRNA Levels in Blood of Lung Transplant Recipients by Competitive Nucleic Acid Sequence-Based Amplification. Journal of Clinical Microbiology. 39(1). 251–259. 16 indexed citations

20.

Greijer, Astrid E., et al.. (1999). Molecular Fine-Specificity Analysis of Antibody Responses to Human Cytomegalovirus and Design of Novel Synthetic-Peptide-Based Serodiagnostic Assays. Journal of Clinical Microbiology. 37(1). 179–188. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact